gr 73632 has been researched along with orvepitant in 1 studies
| Studies (gr 73632) | Trials (gr 73632) | Recent Studies (post-2010) (gr 73632) | Studies (orvepitant) | Trials (orvepitant) | Recent Studies (post-2010) (orvepitant) |
|---|---|---|---|---|---|
| 77 | 1 | 9 | 9 | 3 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisher, A; Ratti, E; Trower, MK; Upton, N | 1 |
1 other study(ies) available for gr 73632 and orvepitant
| Article | Year |
|---|---|
Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour.
Topics: Administration, Oral; Animals; Antipruritics; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Dose-Response Relationship, Drug; Gerbillinae; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Piperidines; Pruritus; Substance P | 2014 |